Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
about
Nanomedicine approaches for corneal diseasesSynthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid)Influence of permeant lipophilicity on permeation across human scleraRecent applications of liposomes in ophthalmic drug delivery.Fungal endophthalmitis.Nanomaterials for ocular drug delivery.Recent advances in ocular drug delivery.Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review.Colloidal drug delivery system: amplify the ocular delivery.Liposomes in topical ophthalmic drug delivery: an update.Ocular drug delivery systems: An overview.In vitro and ex vivo corneal penetration and absorption models.Safety and toxicity of nanomaterials for ocular drug delivery applications.Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis.Relevance of Lipid-Based Products in the Management of Dry Eye Disease.Tailored nanostructured platforms for boosting transcorneal permeation: Box-Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization.Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.Ocular Drug Delivery.
P2860
Q27022253-87FE1FB0-3AF4-495F-8E5A-393AF1B80990Q33719218-6C0555F2-6DCB-42C1-88E2-64844655814BQ34233208-01DAE621-E8D6-42DD-8086-8BF6CFBA7A4BQ34734683-E856C62B-339A-463A-AF3A-BFC907515759Q37960568-A2371F89-E31D-4190-AC0C-16240FDC680AQ38003088-6FBC6704-3DF7-4F66-BABD-77903ABBDF1DQ38059884-2E4C2CAA-85ED-425D-9B96-F31CE27A6CE9Q38085729-2A72B680-85E0-40B3-825A-DD7AD67AE5CDQ38217270-9C58C60F-12D1-4192-BBB1-BA5AEBED7957Q38239330-DEF34B77-F704-448D-A3BC-A8A2C84C6221Q38318837-9A8B42DF-0658-42ED-82BD-423D82D5EC78Q38695101-39104E8D-F4F3-452A-8146-74D5983F4184Q38793489-7F082593-6CF1-4F1C-B5B1-8E708194881AQ38837906-CEF9CC90-D2FD-4EBC-B043-3235A3C6ADF2Q41645060-20272FBB-6813-4033-ADC1-AB02F1EE879BQ43119649-E4E9DEE3-E2EB-4E76-9F4E-9BA2B57DE3A0Q43714357-3412385A-5BDD-4EA4-8A22-8CBA17A9DE3EQ47888817-534F001A-85D4-46F6-8316-136935FB453EQ51122641-DD0F5BC0-BAF5-424A-8EA0-050ED503F335
P2860
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
@en
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
@nl
type
label
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
@en
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
@nl
prefLabel
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
@en
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
@nl
P2093
P2860
P1433
P1476
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
@en
P2093
Dina Fathalla
Ehub A Fouad
Fawzia S Habib
Mohamed S Abdel-Rhaman
P2860
P304
P356
10.1111/J.1755-3768.2009.01584.X
P577
2010-12-01T00:00:00Z